GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
The League of Women Voters of Connecticut (LWV CT) wants followers to "escalate" their response to "Trump's second regime" by joining March On's Free America Walkout today at 2pm in Hartford....
As President Trump mounts a campaign to control the Federal Reserve, the Supreme Court is considering his ability to remove a member of the Fed's governing board....
Carlos Beltran and Andruw Jones were voted into the Baseball Hall of Fame, capping legendary careers that combined power, defense, and decades of excellence on the field....
